Biotechnology

News

35 Years Ago: STS-32 Returns the Long Duration Exposure Facility
NASA

On Jan. 9, 1990, space shuttle Columbia took off on its ninth flight, STS-32, from NASA’s Kennedy Space Center (KSC) in Florida. Its five-person crew of Commander Daniel Brandenstein, Pilot James Wetherbee, and Mission Specialists Bonnie Dunbar, Marsha Ivins,… more…

Experts warn DNA sequencers are vulnerable to bootkit attacks
TechRadar

The iSeq 100 device did not come with standard boot protections, allowing crooks to establish persistence. more…

Why are trees still standing next to burned-out buildings in Los Angeles? The answer is simple
CBC News

As images and videos of the Los Angeles wildfires dominate social media this week, some are questioning why some palm trees have survived next to burned-out homes and cars. more…

FoodTech 2025: The Top Breakthrough Technologies & Investment Outlook From Leading VCs
Forbes

From billion-dollar GLP-1 drugs to skyrocketing cocoa prices, top VCs reveal the trends and technologies reshaping our food system in 2025. more…

20 Game-Changing Innovations Set To Transform Industries In 2025
Forbes

Self-driving cars, specialized robots for medical procedures or factory work, and general-purpose robots as home assistants will be the next major shift for industries. more…

Citizens Of Humanity Group Enters Landmark Partnership To Launch Eco-Friendly Denim Dye
Forbes

Citizens of Humanity Group partners with Pili and Orta to launch Eco-Indigo, a bio-based dye, enhancing sustainability alongside its Regenerative Cotton Initiative. more…

Family Office News In Review: The Headlines That Stood Out In 2024
Forbes

The stories that made the news help paint a picture of what was top of mind for family offices in 2024, and how this might develop in the year to come. more…

Biometrics: The Future Of ID Resolution
Forbes

In a future where behavioral biometrics are central to identity verification, there are a few key actions brands can take to ensure success. more…

Where Should Your Money Be In 2025?
Forbes

Investing is more complicated than ever. Here are insights into five key industries poised to thrive in 2025. more…

Big Blue Chip Dividends? Try These ‘Dogs’ Up To 6.8%
Forbes

The Dogs of the Dow 2025 pay big dividends—up to 6.8%! Collectively they yield three-times what the broader market pays. more…

The Biggest Questions We Have for SEVERANCE Season 2
Nerdist

From unseen Board members and goats, to Irv's Outie and Ms. Casey, these are the biggest questions we have for Severance season 2. The post The Biggest Questions We Have for SEVERANCE Season 2 appeared first on Nerdist. more…

EWC, Canada ETFs Rise Amid Trudeau Resignation
Etf.com

After nearly a decade as prime minister, Justin Trudeau will step down when a new Liberal Party leader is chosen. more…

پیش‌بینی‌های شگفت‌انگیز برای سال ۲۰۲۵ که ۱۰۰ سال پیش مطرح شدند
1pezeshk.com

تصور کنید در سال ۱۹۲۵ ایستاده‌اید. دنیایی که برق هنوز برای بسیاری لوکس به شمار می‌رود، تلویزیون حتی اختراع نشده، و هواپیماها تازه از مرحله آزمایشی عبور کرده‌اند. حالا یک مخترع و آینده‌نگر به شما می‌گوید که در صد سال آینده، تلفن‌هایی خواهید داشت که با لمس انگش… more…

مقایسه داستان‌های علمی تخیلی دوره طلایی و قرن 21 از نظر سوژه‌های کلی
1pezeshk.com

دوره طلایی داستان‌های علمی تخیلی (Golden Age of Science Fiction): شکوفایی تخیل علمی در نیمه قرن بیستم دوره طلایی داستان‌های علمی تخیلی، که تقریباً از دهه ۱۹۳۰ تا ۱۹۵۰ میلادی ادامه داشت، به عنوان عصر شکوفایی این ژانر شناخته می‌شود. این دوران شاهد تولد مفاهیم ج… more…

Gondoljon erre, mielőtt legközelebb kukába dobja a kávézaccot: elképesztő képességét fedezték fel
Hvg.hu

Brazil kutatók szerint a kávézaccban lévő szén segítségével kivonható lehet a talajvízből az egyik leggyakrabban használt gyomirtó szer. more…

Is Remitly Global, Inc. (RELY) the Best Growth Stock to Buy Now Under $25?
Yahoo Entertainment

We recently compiled a list of the 12 Best Growth Stocks Under $25 to Buy Now. In this article, we are going to take a look at where Remitly Global, Inc... more…

Is LendingClub Corporation (LC) the Best Growth Stock to Buy Now Under $25?
Yahoo Entertainment

We recently compiled a list of the 12 Best Growth Stocks Under $25 to Buy Now. In this article, we are going to take a look at where LendingClub Corporation ... more…

Despite Biotech Efforts to Revive Species, Extinction Is Still Forever
Yale.edu

In the last decade, laboratory initiatives to recreate long-extinct species have stirred controversy. Now, scientists increasingly agree "de-extinction" is not possible, but breeding living animals with genes similar to those lost species can be a useful cons… more…

Ethereum Co-Founder Vitalik Buterin Offloads Nearly A Million In Memecoins To Benefit Charities — Dogecoin's Sister Coin NEIRO Plunges 3% After Sale
Yahoo Entertainment

Vitalik Buterin, co-founder of Ethereum (CRYPTO: ETH), sold meme coins gifted to him by project creators on Monday and allocated the proceeds toward his... more…

禽流感死亡首例+新冠、流感病毒發威,美疫苗股飆
Technews.tw

美國出現人類因禽流感死亡的首例,加上新冠、流感病毒齊發威,帶動 mRNA 療法及疫苗生技業者莫德納(Moderna Inc.)等概念股衝高。 Barron's、Business Insider等外電報導,莫德納是少數幾家正在開發H5N1禽流感疫苗的業者之一。H5N1正在北美農場及野生動物群體間快速傳... more…

Tesla shares in 2025 is all about FSD, licensing, teslabot and robotaxi
Next Big Future

I, Brian Wang, made a bunch of correct calls on the stock price movement of Tesla over the past few months. Tesla pulled back after hitting a high of $488. This was after more than doubling from $213 at the end of October, 2024. Tesla disappointed with 495000… more…

Tesla FSD Unsupervised is Already Being Used By Employees
Next Big Future

Elon Musk confirmed that Tesla Full Self Driving Unsupervised (no human driver) is already being used by Tesla employees. Tesla is still on track for robotaxi and unsupervised FSD commercial release in California and Austin later in 2025. $tsla elon just conf… more…

Tesla 20%+ Margins and Possible US-Greenland Deals
Next Big Future

An analysis of one of the most important metrics, auto gross margins, for Tesla share price. Having auto gross margins over 20% is important for Tesla. The key to increasing above Q3 2024 19.6% is continued cost of goods reductions from fewer parts and lower … more…

Amazing SpaceX Raptor 3 Engine Technology
Next Big Future

Youtube channel What About It?, Felix Schlang, dives deep into the technology of the SpaceX Raptor 3 engine. SpaceX has made new alloys for withstanding the heat and have build channels and other structures into the engine. This vastly superior engine outperf… more…

Near the Singularity, Unclear Which Side
Next Big Future

Sam Altman talks about AGI products in 2025 and setting OpenAI sights on ASI (Superintelligence). [OpenAI and Sam Altman] are now confident they know how to build AGI as they have traditionally understood it. They believe that, in 2025, the world may see the … more…

SpaceX Starship Flight 7 Almost Ready
Next Big Future

Expecting a second good booster catch, dummy satellite deployment and Raptor engine relight in orbit and a simulated tower catch for Starship. Flight is now targeting Jan 13 2025, 4pm CST. +00:06:55 Super Heavy landing burn shutdown and catch Planned +00:08:5… more…

Greenland Joining the USA Could Make Greenlanders the Richest in the World
Next Big Future

Greenland joining the USA could make Greenlanders the richest in the world on a per capita basis by quadrupling per capita income and the overall GDP. The US would be able to develop the third largest oil reserves in the Arctic. This is like the Alaska and No… more…

2025 The OMG Year of AI and Humanoid Robots
Next Big Future

The billionaire investors and entrepreneurs at the All in Podcast described 2025 as the year of AI and robots. I, Brian Wang, and Randy Kirk reviewed why and how AI and robots will be transforming the world. Summarizing the key points and claims and providing… more…

Teslabot Ramps to 1 Million by 2027
Next Big Future

Elon Musk made huge announcements that Teslabot will start ramping mass production this year and reach 500,000 to 1 million in 2027. The targets are 5,000 bots in 2025 with Q4 2025 being the start of a factory and 50,000 to 100,000 in 2026 and 500,000 to 1 mi… more…

Blue Origin New Glenn and Amazon Satellite Constellation Finally Becomes Competitive
Next Big Future

Blue Origin plans to finally fly the New Glenn rocket and to get a lot of launches. The first launch is in days. For 2025, they expect to have between 8 and 10 launches, with the capacity for up to 12 launches. In 2026, Blue Origin aims to increase this numbe… more…

Estimating Per Car Robotaxi Revenue and Expenses
Next Big Future

Based upon 2024 pricing, Tesla could start a robotaxi service that offered $5 base fare and $1.00 for booking and $0.7-1.5 per mile ($1.10 average). If this generated 10,000 trips with an average of 6 miles per trip, then this would be : 60,000 miles for $60,… more…

Greenland is Major Front of the Arctic Cold War
Next Big Future

The Arctic an incredibly rich area. It is about the same geographic size as the African continent – about 6% of Earth’s surface area – yet it holds an estimated 22 percent of Earth’s oil and natural gas resource. Most of this the Arctic is poorly explored for… more…

Greenlanders are Pro-Independence, Pro-USA and Wary of China’s Polar Silk Road
Next Big Future

A 2021 survey of Greenland had 69.1 percent of those asked think that Greenland should cooperate more closely with the U.S. Greenland is not a member of the EU. When asking Greenlanders about if Greenland should cooperate with the EU, 65% answer that Greenlan… more…

Pet dogs often overlooked as spreader of antimicrobial-resistant Salmonella
Science Daily

Antibiotic-resistant Salmonella is a serious public health concern that has increased in recent years as the bacteria have developed ways to survive drugs. According to the U.S. Centers for Disease Control and Prevention, people can get Salmonella from eating… more…

Lovande resultat för ny cellterapi mot diabetes
Www.dn.se

För första gången har en patient med typ 1-diabetes fått transplanterade genförändrade celler som inte kräver immundämpande läkemedel. Nu väcks hopp om en botande behandling. more…

Alarming DNA contamination in Pfizer’s mRNA vaccines: latest study reveals CANCER RISKS and regulatory failures
Naturalnews.com

Peer-reviewed research uncovers DNA contamination in Pfizer’s mRNA Covid-19 vaccines exceeding WHO safety limits by 6 to 470 times. Contaminated DNA fragments may integrate into human DNA, raising concerns about gene mutations and cancer. The study was conduc… more…

Microbes can colonize space, produce drugs and create energy
Space Daily

Madison WI (SPX) Jan 07, 2025 After so many years learning how microbes work, researchers are now digitally recreating their inner workings to tackle challenges ranging from climate change to space colonization. In my work as a computational biologist, I … more…

Power Play: The Future of Food
Globalresearch.ca

It takes a book to break down the dynamics that are pushing agro-chemical agriculture to farmers and consumers around the world and to reveal the strength of the diverse organizations who stand in the way of these predatory forces. The post Power Play: The Fu… more…

In vitro and in silico analyses of amino acid substitution effects at the conserved N-linked glycosylation site in hepatitis B virus surface protein on antigenicity, immunogenicity, HBV replication and secretion
Plos.org

The "a" determinant, a highly conformational region within the hepatitis B virus large surface protein (LHBs), is crucial for antibody neutralization and diagnostic assays. Mutations in this area can lead to conformational changes, resulting in vaccination fa… more…

Chlorogenic acid inhibits NLRP3 inflammasome activation through Nrf2 activation in diabetic nephropathy
Plos.org

Diabetic nephropathy (DN) is the single largest cause of end-stage renal disease (ESRD). Inflammation reaction mediated by NLRP3 inflammasome and Nrf2-related oxidative stress have been considered to play a very important role in the progress of diabetic neph… more…

China's Hypersonic Weapons Just Got Deadlier
The National Interest

China is beating the United States in the global tech race. They have both caught up to the Americans in critical technological domains, but the Chinese are now leapfrogging the Americans, too. A recent analysis by Mrigakshi Dixit at the trade publication Int… more…

Sana Biotechnology price target lowered to $7 from $8 at BofA
Yahoo Entertainment

more…

BBGI aims to fuel ships with bio-LNG
Bangkok Post

<p>BBGI, the biotechnology arm of energy conglomerate Bangchak Corporation, plans to supply a cleaner fuel called "bio-LNG" to ships, replacing liquified natural gas (LNG) and supporting the global campaign to reduce greenhouse gas emissions.</p> more…

BIOS flaws expose iSeq DNA sequencers to bootkit attacks
BleepingComputer

BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable devices used for detecting illnesses and developing vaccines. [...] more…

Role and modulation of various spinal pathways for human upper limb control in different gravity conditions
Plos.org

Summary Human movement relies on coordination between the brain, spinal cord, and musculoskeletal system to adapt to various environments and gravity conditions. While the brain plans movements, the spinal cord contributes through reflexes and local control. … more…

Fast yet force-effective mode of supracellular collective cell migration due to extracellular force transmission
Plos.org

Author summary Cellular forces are critical for their collective migration on matrices of various stiffness and topographies. While migrating cells can align collagen fibers, it remains unknown whether such force requirement changes with pre-aligned fibers. O… more…

Preparation of Bovine Serum Albumin Nanospheres via Desolvation: A Study of Synthesis, Characterization, and Aging
Royal Society of Chemistry

Nanoscale, 2025, Accepted ManuscriptDOI: 10.1039/D4NR04682J, Paper Open Access &nbsp This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Blake A. Bartlett, John Klier, Sepideh RazaviSerum albumin has myriad uses in biotechnology… more…

Remarks of National Security Advisor Jake Sullivan A New Frontier for the U.S.-India Partnership
Globalsecurity.org

No description more…

Secretary Antony J. Blinken and Republic of Korea Foreign Minister Cho Tae-yul at a Press Availability
Globalsecurity.org

No description more…

Godzilla Vs Biollante Returns With A New Criterion Collection 4K Blu-Ray Edition
GameSpot

Fans of monster movies are in for a treat with the release of Godzilla vs Biollante: Criterion Collection edition on March 18. This is a new 4K restoration of the 1989 film is available to preorder at Amazon for $35 (was $50). Criterion Collection films rarel… more…

What is a solution biology?
Lifesciencesworld.com

What is Solution Biology? Introduction Solution biology is a rapidly growing field that combines biology, chemistry, and physics to understand […] The post What is a solution biology? appeared first on Life Sciences World. more…

What is residue id protein?
Lifesciencesworld.com

What is Residue ID Protein? Introduction Residue ID protein, also known as residue ID or residue ID protein (RIP), is […] The post What is residue id protein? appeared first on Life Sciences World. more…

Light-regulated microRNAs shape dynamic gene expression in the zebrafish circadian clock
Plos.org

Author summary Our study explored how light affects the biological clock of zebrafish, with a particular focus on the role of miRNAs, small molecules that regulate gene expression. Zebrafish provide a unique model for this research because their internal cloc… more…

Genetic gradual reduction of OGT activity unveils the essential role of O-GlcNAc in the mouse embryo
Plos.org

Author summary Posttranslational modifications of proteins enable cells to rapidly adapt to changes in their environment. Here, we investigated the role of the modification of intracellular proteins by a sugar molecule in the mouse embryo. The O-GlcNAc transf… more…

(GIST OF SCIENCE REPORTER) One Day One Genome Initiative
Iasexamportal.com

(GIST OF SCIENCE REPORTER) One Day One Genome Initiative more…

(GIST OF SCIENCE REPORTER) MCQs December 2024
Iasexamportal.com

(GIST OF SCIENCE REPORTER) MCQs more…

(GIST OF YOJANA) Milestones and Initiatives in Science and Technology
Iasexamportal.com

(GIST OF YOJANA) Milestones and Initiatives in Science and Technology more…

The Glaring Hypocrisy and Embedded Deceptions of the Global Food Giants
Activistpost.com

Colin Todhunter, OffGuardian Bryce Martinez (18) from Pennsylvania is mounting a legal challenge against major food companies, alleging that their ultra-processed foods (UPFs) led to his development of Type 2 diabetes and fatty liver disease at the age of 16.… more…

Is ADMA Biologics, Inc. (ADMA) the Best Growth Stock to Buy Now Under $25?
Yahoo Entertainment

We recently compiled a list of the 12 Best Growth Stocks Under $25 to Buy Now. In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against the other growth stocks. AI is the Most Defining Theme of 2025, Says Expert … more…

Is Lumen Technologies, Inc. (LUMN) the Best Growth Stock to Buy Now Under $25?
Yahoo Entertainment

We recently compiled a list of the 12 Best Growth Stocks Under $25 to Buy Now. In this article, we are going to take a look at where Lumen Technologies, Inc. (NYSE:LUMN) stands against the other growth stocks. AI is the Most Defining Theme of 2025, Says Exper… more…

SEC Clawback Rules: Initial Impacts in the 2024 Proxy Season
Harvard School of Engineering and Applied Sciences

Introduction Malus and clawback provisions allow companies to recover and/or withhold sums or share awards in specific circumstances , such as in situations where values were paid inappropriately or based on inaccurate or misleading information. These policie… more…

AI and the Level of Ordinary Skill: Why Patent Law Must (and Can) Adapt to AI-Augmented Invention
IPWatchdog.com

Imagine a pharmaceutical researcher in 2015 searching for new drug candidates to treat a rare disease. Through traditional methods, they might screen a few thousand compounds over several months, carefully evaluating each candidate's potential based on known … more…

From Marian Keyes to the return of White Lotus - 11 TV shows to get excited about in 2025
TheJournal.ie

We take a look at the new and returning series that everyone will be talking about this year. more…

Mandarini, perché farne il pieno in inverno: tutti i benefici
Ilgiornale.it

Sani e dolci, questi agrumi non possono mancare sulle tavole invernali. Attenzione, però, al consumo eccessivo more…

Standard Glass Lining Technology: Should you subscribe to the IPO?
BusinessLine

SGLT is cheaper than peers on a relative basis, given current growth and business cyclicality risks, is it really cheaper on absolute basis too? more…

View: Returnee entrepreneurs are reshaping India’s future, but barriers must be removed to reap rewards
Economictimes.com

By failing to retain the best and brightest - especially from India - the US has triggered a reverse brain drain that is transforming India into a global innovation powerhouse, while eroding America's leadership in innovation and entrepreneurship. This transf… more…

Parents question federal response after son’s near-death encounter with E. coli
Food Safety News

Colton George, an active 10-year-old boy from Avon, IN, known for his prowess on the baseball field and his agility on the basketball court, was the embodiment of the limitless energy of childhood. But on Nov. 17, 2024, his life took a drastic and terrifying … more…

Unlocking new possibility of Fe3O4@C@Ag nanostructures as an advanced SERS substrate for ultrasensitive detection of low-cross-section urea biomolecules
Royal Society of Chemistry

RSC Adv., 2025, 15,579-592DOI: 10.1039/D4RA07487D, Paper Open Access &nbsp This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Quan-Doan Mai, Dang Thi Hanh Trang, Dong Thi Linh, Nguyen Trung Thanh, Bui Hanh Nhung, Ong Van Hoang,… more…

Apoptotic cell death of stomach cancer lines (AGS) induced by Co-NTB complex through cellular organelles and DNA damage
Royal Society of Chemistry

RSC Adv., 2025, 15,739-747DOI: 10.1039/D4RA06377E, Paper Open Access &nbsp This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.Sri Renukadevi Balusamy, Mani Balamurugan, Sumitha Purushothaman, Sivaraman Somasundara… more…

Fabtech Technologies shares to debut today. GMP hints at maximum listing gains
The Times of India

Fabtech Technologies IPO listing is anticipated to be strong on the NSE SME platform with a 129% GMP over the issue price. The Rs 28 crore IPO saw an overwhelming 700 times subscription. Proceeds will be used for working capital, acquiring Kelvin Air Conditio… more…

India must speed up hybrid technology adoption in pulses, oilseeds to reduce imports, says PK Mishra, Principal Secretary to PM
The Times of India

India must accelerate the adoption of hybrid technology in pulses and oilseeds to address production deficits, despite challenges faced by farmers, Principal Secretary to Prime Minister PK Mishra stated at a national symposium. more…

Puma Biotechnology CFO sells shares worth $32,232
Investing.com

Puma Biotechnology CFO sells shares worth $32,232 more…

UNITY Biotechnology Reports Granting of New Employment Inducement Award
GlobeNewswire

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that on January 6, 2025, the Compens… more…

Zhengye Biotechnology Holding Limited (ZYBT) Announces January 13th IPO
ETF Daily News

Zhengye Biotechnology Holding Limited (ZYBT) is planning to raise $7 million in an IPO on the week of January 13th, IPO Scoop reports. The company plans to issue 1,500,000 shares at a price of $4.00-$5.00 per share. In the last year, Zhengye Biotechnology Hol… more…

Barclays PLC Acquires 47,059 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT)
ETF Daily News

Barclays PLC lifted its holdings in shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 79.6% during the 3rd quarter, Holdings Channel reports. The firm owned 106,174 shares of the company’s stock after purchasing an additional 47,059 shares… more…

Unity Biotechnology (NASDAQ:UBX) Shares Down 26.5% – What’s Next?
ETF Daily News

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Free Report) was down 26.5% during trading on Wednesday . The stock traded as low as $1.24 and last traded at $1.33. Approximately 457,354 shares were traded during trading, a decline of 27% from the average daily v… more…

Puma Biotechnology chief commercial officer sells $29,742 in stock
Investing.com

Puma Biotechnology chief commercial officer sells $29,742 in stock more…

Puma Biotechnology CEO Alan Auerbach sells $106,656 in stock
Investing.com

Puma Biotechnology CEO Alan Auerbach sells $106,656 in stock more…

Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering
GlobeNewswire

Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on live… more…

MAIA Biotechnology enters clinical supply agreement with BeiGene for THIO
Thefly.com

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor… more…

Zhengye Biotechnology 1.5M share IPO priced at $4.00
Thefly.com

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor… more…

Vir Biotechnology stock hits 52-week high of $13.18
Investing.com

Vir Biotechnology stock hits 52-week high of $13.18 more…

Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why
Biztoc.com

On Tuesday, Sana Biotechnology Inc (NASDAQ:SANA) released the initial results from a first-in-human study transplanting UP421, an allogeneic primary islet cell therapy engineered with Sana’s hypoimmune (HIP) technology, into a type 1 diabetes patient without … more…

Vir Biotechnology Catapults 62% On Promising Results In Cancer Treatment
Biztoc.com

Access to this page has been denied because we believe you are using automation tools to browse the website. This may happen as a result of the following: - Javascript is disabled or blocked by an extension (ad blockers for example) - Your browser does not su… more…

Sana Biotechnology (NASDAQ:SANA) Sees Large Volume Increase After Analyst Upgrade
ETF Daily News

Shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) saw strong trading volume on Wednesday after HC Wainwright raised their price target on the stock from $8.00 to $11.00. HC Wainwright currently has a buy rating on the stock. 60,915,641 shares… more…

Lixte Biotechnology Holdings, Inc. Enters into At-the-Market Sales Agreement with WallachBeth Capital, LLC
ETF Daily News

Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) announced on January 6, 2025, that the company has entered into an At-the-Market Sales Agreement with WallachBeth Capital, LLC. Under the agreement, Lixte Biotechnology may offer and sell, through the Agent as… more…

Jeffrey Jerome Ludwig Sells 9,437 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock
ETF Daily News

Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Free Report) insider Jeffrey Jerome Ludwig sold 9,437 shares of Puma Biotechnology stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $3.15, for a total transaction of $29,726… more…

Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Sold by Principal Financial Group Inc.
ETF Daily News

Principal Financial Group Inc. lowered its position in shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 0.7% in the third quarter, HoldingsChannel.com reports. The firm owned 431,411 shares of the company’s stock after selling 3,215 shares duri… more…

Zhengye Biotechnology Holding Limited Prices IPO at $4.00-$5.00 Per Share (ZYBT)
ETF Daily News

Zhengye Biotechnology Holding Limited (ZYBT) is planning to raise $7 million in an IPO on the week of January 13th, IPO Scoop reports. The company plans to issue 1,500,000 shares at $4.00-$5.00 per share. In the last year, Zhengye Biotechnology Holding Limite… more…

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire

SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 43rd Annual J.P. Morgan Healthca… more…

Modus Advisors LLC Takes $41,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)
ETF Daily News

Modus Advisors LLC bought a new position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 4th quarter, Holdings Channel reports. The fund bought 313 shares of the financial services provider’s stock, valued at approximately $41,000. A number of … more…

Puma Biotechnology, Inc. (NASDAQ:PBYI) CEO Alan H. Auerbach Sells 33,841 Shares
ETF Daily News

Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Free Report) CEO Alan H. Auerbach sold 33,841 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $3.15, for a total transaction of $106,599.15. Following the … more…

UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
GlobeNewswire

SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today strengthened the executive leadership team with the appointme… more…

Vir Biotechnology Stock Soars On Prostate Cancer Trial Data - Here's Why
Biztoc.com

On Wednesday, Vir Biotechnology, Inc. (NASDAQ:VIR) stock traded higher after the company presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a variety of HER2-expressing solid tumors, and VIR-5500, which … more…

2,890 Shares in iShares Biotechnology ETF (NASDAQ:IBB) Bought by CWA Asset Management Group LLC
ETF Daily News

CWA Asset Management Group LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,… more…

Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Sold by Principal Financial Group Inc.
ETF Daily News

Principal Financial Group Inc. trimmed its position in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 52.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm o… more…

Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC
Investing.com

Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC more…

Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
GlobeNewswire

MELBOURNE, Australia and SAN FRANCISCO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases… more…

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
GlobeNewswire

First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce Insulin Without Immunosuppression more…

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
GlobeNewswire

Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets. more…

Stocks

Agilent Technologies, Inc.
Alexion Pharmaceuticals, Inc.
Amgen Inc.
Biogen Inc.
Celgene Corporation
Gilead Sciences, Inc.
Illumina, Inc.
Incyte Corporation
Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated
Galapagos NV
ACADIA Pharmaceuticals Inc.
Accelerate Diagnostics, Inc.
Acceleron Pharma Inc.
Achieve Life Sciences, Inc.
Achillion Pharmaceuticals, Inc.
Acorda Therapeutics, Inc.
Adaptimmune Therapeutics plc
ADMA Biologics Inc
Aduro Biotech, Inc.
Advaxis, Inc.
Adverum Biotechnologies, Inc.
AEterna Zentaris Inc.
Aevi Genomic Medicine, Inc.
Affimed N.V.
Agenus Inc.
Agios Pharmaceuticals, Inc.
Aimmune Therapeutics, Inc.
Akebia Therapeutics, Inc.
Alder BioPharmaceuticals, Inc.
Aldeyra Therapeutics, Inc.
Alimera Sciences, Inc.
Alkermes plc
Alliqua BioMedical, Inc.
Alnylam Pharmaceuticals, Inc.
Alpine Immune Sciences, Inc.
AMAG Pharmaceuticals, Inc.
Amicus Therapeutics, Inc.
AnaptysBio, Inc.
Anavex Life Sciences Corp.
Applied Genetic Technologies Corporation
Aptevo Therapeutics Inc.
Aptose Biosciences, Inc.
AquaBounty Technologies, Inc.
Aquinox Pharmaceuticals, Inc.
Arbutus Biopharma Corporation
ARCA biopharma, Inc.
Ardelyx, Inc.
Arena Pharmaceuticals, Inc.
Array BioPharma Inc.
Arrowhead Pharmaceuticals, Inc.
Ascendis Pharma A/S
Atara Biotherapeutics, Inc.
Athersys, Inc.
aTyr Pharma, Inc.
Audentes Therapeutics, Inc.
Aurinia Pharmaceuticals Inc
Auris Medical Holding AG
AVEO Pharmaceuticals, Inc.
Axovant Sciences Ltd.
AzurRx BioPharma, Inc.
BeiGene, Ltd.
Bellicum Pharmaceuticals, Inc.
Benitec Biopharma Limited
Bioblast Pharma Ltd.
Biocept, Inc.
BioCryst Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc.
Bio-Path Holdings, Inc.
Bio-Techne Corp
bluebird bio, Inc.
Blueprint Medicines Corporation
Calithera Biosciences, Inc.
Capricor Therapeutics, Inc.
Cara Therapeutics, Inc.
CareDx, Inc.
CASI Pharmaceuticals, Inc.
Catabasis Pharmaceuticals, Inc.
Catalyst Biosciences, Inc.
Celldex Therapeutics, Inc.
Cellect Biotechnology Ltd.
Cellectar Biosciences, Inc.
Cellectis S.A.
Cellular Biomedicine Group, Inc.
Champions Oncology, Inc.
ChemoCentryx, Inc.
Chiasma, Inc.
Chimerix, Inc.
China Biologic Products Holdings, Inc.
Cidara Therapeutics, Inc.
Cleveland BioLabs, Inc.
Clovis Oncology, Inc.
Co-Diagnostics, Inc.
CohBar, Inc.
Coherus BioSciences, Inc.
Compugen Ltd.
Conatus Pharmaceuticals Inc.
Concert Pharmaceuticals, Inc.
ContraFect Corporation
Corbus Pharmaceuticals Holdings, Inc.
Corium International, Inc.
CRISPR Therapeutics AG
Curis, Inc.
Cyclacel Pharmaceuticals, Inc.
CymaBay Therapeutics Inc.
Cytokinetics, Incorporated
CytomX Therapeutics, Inc.
Cytori Therapeutics Inc
Dare Bioscience, Inc.
DBV Technologies S.A.
Deciphera Pharmaceuticals, Inc.
Dermira, Inc.
Dicerna Pharmaceuticals, Inc.
Diffusion Pharmaceuticals Inc.
Dynavax Technologies Corporation
EDAP TMS S.A.
Edge Therapeutics, Inc.
Editas Medicine, Inc.
Eiger BioPharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc.
Endocyte, Inc.
ENDRA Life Sciences Inc.
Epizyme, Inc.
Erytech Pharma S.A.
Esperion Therapeutics, Inc.
Evofem Biosciences, Inc.
Evogene Ltd.
Exact Sciences Corporation
Exelixis, Inc.
Fate Therapeutics, Inc.
Fennec Pharmaceuticals Inc.
Fibrocell Science Inc
FibroGen, Inc
Five Prime Therapeutics, Inc.
Flexion Therapeutics, Inc.
Fortress Biotech, Inc.
Forward Pharma A/S
Galectin Therapeutics Inc.
Genetic Technologies Ltd
Genocea Biosciences, Inc.
Genomic Health, Inc.
Geron Corporation
Global Blood Therapeutics, Inc.
GlycoMimetics, Inc.
GTx, Inc.
Halozyme Therapeutics, Inc.
Harvard Bioscience, Inc.
Heat Biologics, Inc.
Heron Therapeutics, Inc.
Histogenics Corporation
HTG Molecular Diagnostics, Inc.
Idera Pharmaceuticals, Inc.
Immune Design Corp.
ImmunoGen, Inc.
Immunomedics, Inc.
Immuron Limited
Immutep Limited
Infinity Pharmaceuticals, Inc.
Insmed, Inc.
Insys Therapeutics, Inc.
Intellia Therapeutics, Inc.
Intellipharmaceutics International Inc.
Intra-Cellular Therapies Inc.
InVivo Therapeutics Holdings Corp.
Ionis Pharmaceuticals, Inc.
Iovance Biotherapeutics, Inc.
Jounce Therapeutics, Inc.
Kamada Ltd.
Karyopharm Therapeutics Inc.
Kazia Therapeutics Limited
Keryx Biopharmaceuticals, Inc.
Kura Oncology, Inc.
La Jolla Pharmaceutical Company
LEAP THERAPEUTICS, INC.
Lexicon Pharmaceuticals, Inc.
Ligand Pharmaceuticals Incorporated
Loxo Oncology, Inc.
Luminex Corporation
MacroGenics, Inc.
MannKind Corporation
MediciNova, Inc.
Meridian Bioscience Inc.
Merrimack Pharmaceuticals, Inc.
Mersana Therapeutics, Inc.
Merus N.V.
Mesoblast Limited
Microbot Medical Inc.
Midatech Pharma PLC
MiMedx Group, Inc
Minerva Neurosciences, Inc
Miragen Therapeutics, Inc.
Mirati Therapeutics, Inc.
Molecular Templates, Inc.
Momenta Pharmaceuticals, Inc.
Motif Bio plc
Myriad Genetics, Inc.
Nabriva Therapeutics plc
NanoString Technologies, Inc.
NantKwest, Inc.
Natera, Inc.
Nektar Therapeutics
Neptune Technologies & Bioresources Inc
Neuralstem, Inc.
Neurocrine Biosciences, Inc.
NewLink Genetics Corporation
Novavax, Inc.
Novelion Therapeutics Inc.
NuCana plc
Ohr Pharmaceuticals, Inc.
Omeros Corporation
Oncobiologics, Inc.
OncoMed Pharmaceuticals, Inc.
Onconova Therapeutics, Inc.
OpGen, Inc.
Ophthotech Corporation
Opiant Pharmaceuticals, Inc.
Opko Health, Inc.
Organovo Holdings, Inc.
Otonomy, Inc.
OvaScience Inc.
Pacific Biosciences of California, Inc.
Paratek Pharmaceuticals, Inc.
PDL BioPharma, Inc.
Pieris Pharmaceuticals, Inc.
Pluristem Therapeutics, Inc.
Prana Biotechnology Ltd
Precipio, Inc.
Progenics Pharmaceuticals Inc.
ProQR Therapeutics N.V.
Protagonist Therapeutics, Inc.
Proteon Therapeutics, Inc.
Proteostasis Therapeutics, Inc.
Prothena Corporation plc
PTC Therapeutics, Inc.
Pulmatrix, Inc.
Puma Biotechnology Inc
Radius Health, Inc.
Recro Pharma, Inc.
Redhill Biopharma Ltd.
REGENXBIO Inc.
Repligen Corporation
Retrophin, Inc.
Rhythm Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc.
RTI Surgical, Inc.
RXi Pharmaceuticals Corporation
Sangamo Therapeutics, Inc.
Sarepta Therapeutics, Inc.
Savara, Inc.
Seattle Genetics, Inc.
Selecta Biosciences, Inc.
SELLAS Life Sciences Group, Inc.
SenesTech, Inc.
Seres Therapeutics, Inc.
Sierra Oncology, Inc.
Sinovac Biotech, Ltd.
Soligenix, Inc.
Sophiris Bio, Inc.
Sorrento Therapeutics, Inc.
Spark Therapeutics, Inc.
Spectrum Pharmaceuticals, Inc.
Stellar Biotechnologies, Inc.
Stemline Therapeutics, Inc.
Strongbridge Biopharma plc
Summit Therapeutics plc
Sunesis Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc.
Synlogic, Inc.
Syros Pharmaceuticals, Inc.
T2 Biosystems, Inc.
TESARO, Inc.
TG Therapeutics, Inc.
Therapix Biosciences Ltd.
Titan Pharmaceuticals, Inc.
Tocagen Inc.
TRACON Pharmaceuticals, Inc.
Trevena, Inc.
Trillium Therapeutics Inc.
TrovaGene, Inc.
Ultragenyx Pharmaceutical Inc.
uniQure N.V.
UroGen Pharma Ltd.
Vanda Pharmaceuticals Inc.
Vascular Biogenics Ltd.
VBI Vaccines, Inc.
Veracyte, Inc.
Verastem, Inc.
Vermillion, Inc.
Vical Incorporated
Viking Therapeutics, Inc.
VistaGen Therapeutics, Inc.
Vital Therapies, Inc.
Voyager Therapeutics, Inc.
vTv Therapeutics Inc.
WAVE Life Sciences Ltd.
XBiotech Inc.
Xencor, Inc.
Xenetic Biosciences, Inc.
Xenon Pharmaceuticals Inc.
XOMA Corporation
XTL Biopharmaceuticals Ltd.
Zafgen, Inc.
Zai Lab Limited
Zealand Pharma A/S
ZIOPHARM Oncology Inc
Kadmon Holdings, Inc. (KDMN)
Pfenex Inc. (PFNX)
Intrexon Corporation (XON)
Myovant Sciences Ltd. (MYOV)
Monster Digital, Inc. (INNT)
Orgenesis Inc. (ORGS)
AmpliPhi Biosciences Corporation
Asterias Biotherapeutics Inc. Common Series A
Actinium Pharmaceuticals Inc. (Delaware)
Can-Fite Biopharma Ltd Sponsored ADR (Israel)
CollPlant Holdings Ltd.
Cel-Sci Corporation ($0.001 Par Value)
Emergent Biosolutions Inc.
Enzo Biochem Inc. ($0.01 Par Value)
Hemispherx BioPharma Inc.
iBio Inc.
India Globalization Capital Inc.
IsoRay Inc.
Matinas Biopharma Holdings Inc.
Navidea Biopharmaceuticals Inc.
NovaBay Pharmaceuticals Inc.
NanoViricides Inc.
Oragenics Inc.
Palatin Technologies Inc.
Rexahn Pharmaceuticals Inc.
Synthetic Biologics Inc.
Vaxart Inc.
Senesco Technologies Inc. (ELOX)
Sesen Bio, Inc.
Correvio Pharma Corp.
Standard Diversified Inc. Class A
DiaMedica Inc